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Abstract:  This study reports the effect of Spilanthes acmella Murr. extracts on 
phenylephrine-induced contraction of rat thoracic aorta as well as their antioxidant activity. 
Results show that the extracts exert maximal vasorelaxations in a dose-dependent manner, 
but their effects are less than acetylcholine-induced nitric oxide (NO) vasorelaxation. 
Significant reduction of vasorelaxations is observed in both N
G-nitro-L-arginine methyl 
ester (L-NAME) and indomethacin (INDO). In the presence of L-NAME plus INDO, 
synergistic effects are observed, leading to loss of vasorelaxation of both acetylcholine and 
the extracts. Similarly, the vasorelaxations of the extracts are completely abolished upon 
the removal of endothelial cells. This demonstrates that the extracts exhibit vasorelaxation 
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via partially endothelium-induced NO and prostacyclin in a dose-dependent manner. 
Significantly, the ethyl acetate extract exerts immediate vasorelaxation (ED50 76.1 ng/mL) 
and is the most potent antioxidant (DPPH assay). The chloroform extract shows the highest 
vasorelaxation and antioxidation (SOD assay). These reveal a potential source of 
vasodilators and antioxidants. 
 
Keywords:  Spilanthes acmella Murr., vasorelaxant, antioxidant activities, nitric oxide, 
prostacyclin, thoracic aorta. 
 
 
 
1. Introduction 
 
Spilanthes acmella Murr. (para-cress or toothache plant) is a medicinal plant of the Compositae 
family [1]. It is known in Thai as Phak-Kratt Huawaen and has long been used as a traditional 
medicine for toothache, headache and treatment of asthma, rheumatism, fever, sore throat and 
haemorrhoids [1-3]. Its root decoction has been used as a laxative and diuretic drug [2, 4]. It is an 
annual or short-lived herb, spreads in low open places and requires moist soil [5]. Its flowers and 
leaves have a pungent taste, accompanied with tingling and numbness [2]. 
Constituents found in Spilanthes acmella Murr. were spilanthol, isobutylamide derivatives [6, 7], α-
and β-amyrin esters, stigmasterol, myricyl alcohol including sitosterol glucosides [8] and triterpenoidal 
saponins [9]. Spilanthol showed interesting bioactivities, e.g. strong local anesthetic [10], analgesic 
[11, 12] and insecticidal activities [3]. Crude flower head extracts of the plant exhibited potent 
ovicidal, marked larvicidal (LC50 of 61.43 ppm) and pupicidal activities [13, 14]. The extracts were 
also shown to exhibit pancreatic lipase inhibition which has potential as candidates for weight loss and 
obesity control [15]. In addition, the crude flower head extracts displayed strong diuretic action which 
caused marked increase in urine Na
+, K
+ and a reduction in the osmolarity of urine [16]. Moreover, it 
has been used as anti-toothache formulation for pain relieving within 2-10 min and also useful in 
treating the swelling and infection of gums [17]. The Spilanthes acmella is one of the active 
ingredients in compositions for acute- or long-term treatment of microbial infections, particularly, oral 
pathogenic microorganisms, dental caries, periodontosis, gum disease, gum bleeding and/or plaque 
reduction [18]. In addition, its root powder extract is very effective in treating HIV/AID infection [19]. 
Presently, cardiovascular disease is one of the most important public health concerns, accountable for 
morbidity and mortality. Thus new vasoactive ingredients that influence the endothelial cells, which 
are key regulating cells in the vessel wall, are the striking areas. So far, the effect of Spilanthes 
acmella Murr. on vascular function has not been reported. In this regard, it was of great interest to 
explore its medicinal value with regards to cardiovascular functions such as regulation of vascular 
tone. In the present study, we have investigated the effects of Spilanthes acmella Murr. extracts on rat 
thoracic aorta and its mechanism of action as well as its antioxidant activity. Int. J. Mol. Sci. 2008, 9                                     
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2. Results 
 
2.1. Components and HPLC (high performance liquid chromatography) profiles of the extracts 
 
Preliminary screening of components in the Spilanthes acmella Murr. extracts was performed using 
thin layer chromatography (TLC) chromatograms, IR and 
1H-NMR spectra. It was found that hexane, 
chloroform, ethyl acetate and methanol extracts showed UV absorption on TLC. The ethyl acetate and 
methanol extracts exhibited very strong absorptions, compared to the chloroform extract. The IR 
spectra of the extracts showed absorptions (cm
-1) corresponding to OH (3360-3385), CH (2850-2942), 
CO (1710-1736), 1454-1574 and C-O (1047-1385) functions. The ethyl acetate and methanol extracts 
exhibited very strong OH and CO (ester or acid) and strong C-O absorptions. The chloroform extract 
displayed strong OH, medium CO (ester or acid) and C-O absorptions. The hexane extract showed 
strong CO (ester or acid), but medium OH and weak C-O absorptions. All the extracts showed strong 
CH absorptions, the the hexane extract displaying the strongest ones. The 
1H-NMR spectra of the 
hexane and chloroform extracts exhibited the presence of triterpenes (δ 0.9-2.4, 3.4-3.7, 4.1-4.3 and 
5.3-5.4). The ethyl acetate extract showed the signals of triterpenes and aromatics (δ 0.84-2.4, 3.5-4.3, 
5.3-5.5 and 6.8-7.8). The methanol extract displayed the presence of aromatic protons (δ 6.8-8.4). 
Based on the IR and 
1H-NMR data, it may be concluded that the hexane and chloroform extracts 
contain triterpenes and long chain hydrocarbon esters or alcohols. The ethyl acetate extract contains 
triterpene esters and phenolic compounds, while the components of the methanol extract are 
presumably phenolic compounds and esters. 
Profiles of the extracts were obtained by reversed phase HPLC running from a more polar to less 
polar mobile phase (Figure 1). Major nonpolar components of the extracts appeared in the 48.80-58.38 
min retention time (RT) range. In the hexane extract the major component (66.06%) was found at a RT 
of 52.56 min, while th major components of the chloroform (65.72%), ethyl acetate (67.34%) and 
methanol (64.18%) extracts were observed at RTs of 52.54, 52.58 and 52.60 min, respectively. It was 
noted that minor contents (0.22-4.72%) of polar components in chloroform and ethyl acetate extracts 
appeared at RTs of 18.27-33.73 min. However, the methanol extract showed a minor polar component 
(2.64%) at a RT of 23.82 min (Table 1). 
 
2.2. Vasorelaxant activity 
 
Effects of Spilanthes acmella Murr. extracts (hexane, chloroform, ethyl acetate and methanol) on 
vascular function of rat thoracic aorta precontracted with phenylephrine (PE) were investigated under 
various conditions; in the presence or absence of inhibitors, namely, N
G-nitro-L-arginine methyl ester 
(L-NAME) and indomethacin (INDO) and under removal of functional endothelial cells. In addition, 
the effects of acetylcholine (ACh) as a positive control, sodium nitroprusside (SNP) a negative control 
and vehicle such as polyethyleneglycol (PEG) were studied. Results confirmed that the vasorelaxation 
of ACh was related to nitric oxide (NO). 
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Figure 1. HPLC profiles of plant extracts in hexane (a, 228.0 nm), chloroform (b, 228.0 
nm), ethyl acetate (c, 228.0 nm), and methanol (d, 280.0 nm). 
 Int. J. Mol. Sci. 2008, 9                                     
 
 
2728
Table 1. Retention times and area peaks of plant extracts. 
Extract 
RT  
(min) 
Area 
(%) 
Extract 
RT  
(min) 
Area 
(%) 
Hexane 48.80  3.86  Chloroform
b 25.65  0.61 
 49.58  4.20      27.20  0.37 
 50.42  7.79      27.81  0.55 
 51.64  5.38      30.95  1.69 
 52.56  66.06      32.14  4.72 
 56.59  5.09        
 57.76  0.97  Ethyl  acetate
b 18.27  2.55 
 58.38  6.64      19.92  0.84 
        22.89  1.57 
Chloroform
a 52.54 65.72      30.95  0.72 
        32.17  0.22 
Ethyl acetate
a 52.58  67.34      33.73  0.38 
           
Methanol
a 52.60  64.18  Methanol
b 23.82  2.64 
a Minor contents at RT range 48-58 min are similar to hexane extract, but data are not 
shown. 
b Minor contents of polar components at RT range 18.27-33.73 min. 
 
2.3. Effect of Spilanthes acmella Murr. extracts on the vascular function of rat thoracic aorta in the 
absence or presence of a NOS inhibitor (L-NAME, 1 mM) 
 
2.3.1. Hexane extract 
 
In the rat aortic ring preparation, the hexane extract exerted vasorelaxation in the dose-dependent 
manner, but PEG showed no effect on the vessels (Figure 2 and Table 2). The activity of the hexane 
extract reached up to 65.7% of the Rmax induced by ACh (110.1%) showing ED50 3.60×10
-7 mg/mL 
and 4.66×10
-7 M, respectively. This indicated that the hexane extract likely acted as a partial agonist. 
In the presence of a NOS inhibitor (L-NAME), the dose-response curve of hexane extract was shifted 
to the right, with Rmax 33.5% and ED50 4.80×10
-7 mg/mL. This suggested that the hexane extract 
caused vasorelaxation by partially producing NO from the endothelial cells, while PEG had no effect 
on induction of vasorelaxation. 
 
2.3.2. Chloroform extract 
 
Similarly, the chloroform extract showed dose-dependent vasorelaxation (Figure 3 and Table 2). 
The Rmax of ACh and the chloroform extract were 120.6 and 96.6%, with ED50 9.43×10
-7 M and 
4.28×10
-7mg/mL, respectively. In the presence of L-NAME, the dose-response curve of chloroform 
extract was shifted to the right. The extract showed Rmax 54.4% and ED50 1.00×10
-6 mg/mL, whereas 
Rmax and ED50 of ACh were 82.1% and 3.61×10
-7 M, respectively. This demonstrated that the 
chloroform extract exhibited vasorelaxation by partly production of NO from the endothelial cells. Int. J. Mol. Sci. 2008, 9                                     
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Table 2. Vasorelaxant activity of Spilanthes acmella Murr. extracts on rat thoracic aorta. 
Compound 
Vasorelaxant activity
Without L-NAME With L-NAME (1 mM)
Rmax (%) ED50 (mg/mL)  Rmax (%)  ED50 (mg/mL) 
Hexane extract
a  65.67 ± 0.984  3.601×10
-7  33.49 ± 1.122  4.805×10
-7 
ACh
a  110.08 ± 1.801  4.657×10
-7 NA  NA 
    
Chloroform extract
b  96.64 ± 1.112  4.279×10
-7  54.38 ± 0.575  1.003×10
-6 
ACh
a  120.63 ± 1.671  9.428×10
-7  82.15 ± 1.158  3.611×10
-7 
    
Ethyl acetate extract
b  81.64 ± 0.530  7.614×10
-8  53.99 ± 1.517  3.885×10
-7 
ACh
b  115.47 ± 0.951  5.912×10
-7  83.36 ± 1.169  5.650×10
-7 
    
Methanol extract
a  65.09 ± 0.409  9.550×10
-7  33.38 ± 0.403  1.375×10
-6 
ACh
a  120.69 ± 0.220  8.183×10
-7  82.01 ± 0.582  3.427×10
-7 
    
ACh
b  119.20 ± 0.344  7.878×10
-7  80.86 ± 0.368  4.163×10
-7 
SNP
b  120.53 ± 2.270  1.727×10
-7  114.84 ± 0.716  3.171×10
-7 
a: data obtained from 6 experiments, b: data obtained from 5 experiments 
ED50 of ACh and SNP are expressed as molar, NA: not tested, p < 0.05 
 
Figure 2. Effect of hexane extract on the vascular function of rat thoracic aorta in the 
absence or presence of NOS inhibitor (L-NAME, 1 mM) compared with those of ACh  
and PEG. 
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Data represent as means ± s.e.m. of 6 experiments, each performed in duplicate. 
· p < 0.05, ACh versus PEG,  
·· p < 0.05, ACh versus hexane extract,  
+ p < 0.05, hexane extract versus hexane extract + L-NAME,  
++ p < 0.05, PEG versus hexane extract 
a: hexane extract as mg/mL, ACh as molar Int. J. Mol. Sci. 2008, 9                                     
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2.3.3. Ethyl acetate extract 
 
A similar result was obtained from ethyl acetate extract, showing vasorelaxation in the dose-
dependent manner (Figure 4 and Table 2). The ACh and plant extract exerted Rmax 115.5 and 81.6%, 
with ED50 of 5.91×10
-7 M and 7.61×10
-8 mg/mL, respectively. This showed that the ethyl acetate 
extract possibly acted as a partial agonist. In the presence of L-NAME, the dose-response curve of the 
extract was shifted to the right with Rmax 54.0%, ED50 3.88×10
-7 mg/mL, whereas the Rmax and ED50 of 
ACh were 83.4% and 5.65×10
-7 M, respectively. This suggested that the ethyl acetate extract caused 
vasorelaxation by partly synthesis of NO from the endothelial cells. 
 
2.3.4. Methanol extract 
 
The methanol extract displayed vasorelaxant activity in a dose-dependent manner (Figure 5 and 
Table 2). The Rmax of ACh and extract were 120.7 and 65.1% with ED50 8.18×10
-7 M and   
9.55×10
-7 mg/mL, respectively. This indicated that the extract possibly acted as partial agonist. In the 
presence of L-NAME, the dose-response curve of extract was shifted to the right with Rmax 33.4% and 
ED50 1.38×10
-6 mg/mL, whereas the Rmax and ED50 of ACh were 82.0% and 3.43×10
-7M, respectively. 
This illustrated that the methanol extract exerted vasorelaxation by partial NO production from the 
endothelial cells. 
 
Figure 3. Effect of CHCl3 extract and ACh on the vascular function of rat thoracic aorta in 
the absence or presence of  1 mM L-NAME. 
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Data represent as means ± s.e.m. of 5-6 experiments, each performed in duplicate. 
· p < 0.05, ACh versus ACh+L-NAME,  
·· p < 0.05, ACh versus CHCl3 extract,  
+ p < 0.05, CHCl3 extract versus CHCl3 extract+L-NAME  
a: CHCl3 extract as mg/mL, ACh as molar 
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Figure 4. Effect of EtOAc extract and ACh on the vascular function of rat thoracic aorta in 
the absence or presence of 1 mM L-NAME. 
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Data represent as means ± s.e.m. of 5 experiments, each performed in duplicate. 
· p < 0.05, ACh versus ACh+L-NAME,  
·· p < 0.05, ACh versus EtOAc extract,  
+ p < 0.05, EtOAc extract versus EtOAc extract+L-NAME 
a: EtOAc extract as mg/mL, ACh as Molar 
 
Figure 5. Effect of MeOH extract and ACh on the vascular function of rat thoracic aorta in 
the absence and presence of 1 mM L-NAME. 
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Data represent as means ± s.e.m. of 6 experiments, each performed in duplicate. 
· p < 0.05, ACh versus ACh+L-NAME,  
·· p < 0.05, ACh versus MeOH extract,  
+ p < 0.05, MeOH extract versus MeOH extract+L-NAME 
a: MeOH extract as mg/mL, ACh as molar 
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2.4. Effect of Spilanthes acmella Murr. on the vascular function of rat thoracic aorta in the absence of 
endothelial cells 
 
The vasorelaxation of Spilanthes acmella Murr. extracts was examined with and without intact 
endothelial cells, comparing with ACh. The results (Table 3) illustrated that the vasorelaxation of all 
the tested extracts was abolished when endothelial cells were removed. An example, the dose-response 
curve of the ethyl acetate extract is shown in Figure 6. Similar results were observed for the control, 
ACh. This confirmed that the vasorelaxant activity of Spilanthes acmella Murr. extracts was mediated 
via endothelial cells producing NO. 
 
Table 3. Effect of endothelial cells on vasorelaxant activity of Spilanthes acmella  
Murr. extracts. 
Compound
a 
Vasorelaxant activity 
+Et -Et 
Rmax (%)  ED50 (mg/mL) Rmax (%)  ED50 (mg/mL) 
Hexane extract  64.82 ± 0.870  2.556×10
-7 0  - 
ACh  104.31 ± 1.595  2.440×10
-7  7.16 ± 2.010  3.128×10
-7 
Chloroform extract  98.00 ± 0.694  4.422×10
-7  5.64 ± 0.080  3.128×10
-7 
ACh  120.36 ± 0.823  7.534×10
-7  7.42 ± 0.159  3.128×10
-7 
Ethyl acetate extract  81.68 ± 0.682  7.638×10
-8 0  - 
ACh  118.58 ± 0.550  7.477×10
-7  7.42 ± 0.159  3.128×10
-7 
Methanol extract  65.62 ± 0.651  1.002×10
-6 0  - 
ACh  119.93 ± 0.495  7.967×10
-7  7.28 ± 0.138  3.128×10
-7 
a: data obtained from 4 experiments, ED50 of ACh is expressed as molar, p < 0.05 
+Et: in the presence of endothelial cells, -Et: in the absence of endothelial cells 
 
2.5. Effect of Spilanthes acmella Murr. on the vascular function of rat thoracic aorta in the presence of 
a cyclooxygenase inhibitor (INDO) 
 
The vasorelaxation of Spilanthes acmella Murr. extracts was studied in the presence of INDO   
(1 mM), comparing with L-NAME (1 mM) and L-NAME plus INDO. The results are summarized in 
Table 4 and some dose-response curves are shown in Figures 7-9. It was observed that in each 
experiment with L-NAME (1 mM) or INDO (1 mM) the vasorelaxation was reduced in a dose-
dependent manner. The inhibition effect of the INDO was stronger than that of L-NAME. However, 
the antagonist effects of L-NAME or INDO were more pronounced in the case of L-NAME plus 
INDO. Such effects were not observed in the SNP dose-response curves. Interestingly, the 
vasorelaxations were abolished by all the tested extracts and by the ACh in the presence of L-NAME 
(1 mM) plus INDO (1 mM), but no significant change was noted in the case of SNP. The results 
confirmed that the extracts caused partial vasorelaxation through endothelial cells producing NO and 
prostacyclin (PGI2). Int. J. Mol. Sci. 2008, 9                                     
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Table 4. Effect of inhibitors on vasorelaxant activity of Spilanthes acmella Murr. extracts. 
Compound 
Vasorelaxant activity 
-Inhibitor +L-NAME (1 mM)  +INDO (1 mM) 
+L-NAME (1 mM) + 
INDO (1 mM) 
Rmax 
(%) 
ED50 
(mg/mL) 
Rmax 
(%) 
ED50 
(mg/mL) 
Rmax (%) 
ED50 
(mg/mL) 
Rmax (%) 
ED50 
(mg/mL) 
ACh
a 
121.74 ± 
1.440 
9.990×10
-7 
81.34 ± 
0.770 
5.455×10
-7 
68.78 ± 
0.919 
4.575×10
-7 0  - 
Hexane 
extract
a 
69.05 ± 
0.693 
5.016×10
-7 
31.29 ± 
0.619 
3.163×10
-7 
26.64 ± 
0.768 
3.162×10
-7 0  - 
Chloroform 
extract
a 
94.25 ± 
0.873 
5.278×10
-7 
51.62 ± 
0.706 
1.598×10
-6 
46.70 ± 
0.511 
6.661×10
-7 0  - 
Ethyl acetate 
extract
a 
85.84 ± 
1.196 
8.552×10
-8 
52.95 ± 
0.976 
7.804×10
-7 
44.48 ± 
0.350 
3.133×10
-7 0  - 
Methanol 
extract
b 
65.56 ± 
0.535 
9.444×10
-7 
33.24 ± 
0.608 
1.404×10
-6 
32.19 ± 
0.420 
1.072×10
-6 0  - 
SNP
b 
120.84 ± 
1.176 
3.164×10
-7 
116.70 ± 
1.290 
3.167×10
-7 
112.93 ± 
0.613 
3.155×10
-7 
104.98 ± 
1.407 
3.165×10
-7 
a: data obtained from 5 experiments, b: data obtained from 6 experiments 
ED50 of ACh and SNP are expressed as molar, p < 0.05, -Inhibitor: in the absence of L-NAME or INDO 
 
Figure 6. Effect of EtOAc extract and ACh on the vascular function of rat thoracic aorta 
under removal of endothelium (-et) compared with intact endothelium (+et). 
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Data represent as means ± s.e.m. of 4 experiments, each performed in duplicate. 
· p < 0.05, ACh(+et) versus ACh(-et), ·· p < 0.05, ACh(+et) versus EtOAc extract (+et),  
+ p < 0.05, EtOAc extract (+et) versus EtOAc extract (-et) 
a: EtOAc extract as mg/mL, ACh as Molar 
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Figure 7. Effect of ACh in the presence of L-NAME plus INDO on the vascular function 
of rat thoracic aorta precontracted with PE. 
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Data represent as means ± s.e.m. of 5 experiments, each performed in duplicate. 
· p < 0.05, ACh versus ACh+L-NAME,  
·· p < 0.05, ACh versus ACh+INDO,  
+ p < 0.05, ACh versus ACh+L-NAME+INDO 
 
Figure 8. Effect of EtOAc extract on the vascular function of rat thoracic aorta in the 
presence of INDO compared with L-NAME and with L-NAME plus INDO. 
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Data represent as means ± s.e.m. of 5 experiments, each performed in duplicate. 
· p < 0.05, EtOAc extract versus EtOAc extract+L-NAME,  
·· p < 0.05, EtOAc extract versus EtOAc extract+INDO,  
+ p < 0.05, EtOAc extract versus EtOAc extract+L-NAME+INDO 
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Figure 9. Effect of SNP in the presence of L-NAME, INDO and L-NAME plus INDO on 
the vascular function of rat thoracic aorta. 
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Data represent as means ± s.e.m. of 6 experiments, each performed in duplicate. 
· p < 0.05, SNP versus SNP+L-NAME,  
·· p < 0.05, SNP versus SNP+INDO,  
+ p < 0.05, SNP versus SNP+L-NAME+INDO 
 
2.6. Antioxidant activity 
 
The antioxidant activity of Spilanthes acmella Murr. extracts was measured using DPPH and SOD 
assays. The results (Table 5) showed that all the tested extracts exhibited antioxidative activity. In 
DPPH assay (Figure 10) at 200 µg/mL, the ethyl acetate and methanol extracts displayed comparable 
activity and the highest radical scavenging activity (47.90 and 47.76%) with IC50 216 and 223 µg/mL, 
while  α-tocopherol (a positive control) showed antioxidant activity with IC50  6.67  µg/mL. The 
chloroform extract exhibited 29.82% radical scavenging activity. The hexane extract produced some 
activity (4.90% radical scavenging). 
 
Table 5. Radical scavenging activity and NBT inhibition of extracts. 
Extract 
% Radical scavenging activity
a 
(DPPH assay); 200 μg/mL 
% NBT inhibition
b 
(SOD assay); 200 μg/mL 
Hexane 4.90  0.41 
Chloroform 29.82  57.92 
Ethyl acetate  47.90  33.05 
Methanol 47.76  47.02 
a: α-Tocopherol was used as a positive control.  
b: Native SOD (8.1 U) from bovine erythrocytes was used as a positive control. 
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The SOD assay at 200 µg/mL (Figure 11), the chloroform extract showed the highest antioxidant 
activity (57.92% NBT inhibition). The ethyl acetate and methanol extracts exhibited weak to moderate 
SOD activity. 
 
Figure 10. Radical scavenging activity of α-tocopherol and extracts. 
Concentration (μg/mL)
0 100 200 300 400 500
%
 
R
a
d
i
c
a
l
 
s
c
a
v
e
n
g
i
n
g
 
a
c
t
i
v
i
t
y
0
10
20
30
40
50
60
70
80
90
100
α-TocopherolIC50 = 6.67 μg/mL
Hexane extract
Chloroform extract IC50 = 381 μg/mL
Methanol extract IC50 = 223 μg/mL
Ethyl acetate extract IC50 = 216 μg/mL
 
 
Figure 11. Superoxide dismutase activity of crude extracts. 
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3. Discussion 
 
We have disclosed the effect of Spilanthes acmella Murr.extracts on phenylephrine-induced 
contraction of rat thoracic aorta. All the tested plant extracts elicit maximal vasorelaxations in a dose-
related manner, although such vasorelaxations are less than those produced by ACh. The 
vasorelaxations are exerted by partial production of NO from functional endothelial cells, which is 
demonstrated by a significant reduction of the activity in the presence L-NAME (Table 2).  
The chloroform extract exhibited the highest Rmax of 96.6%, compared to the other extracts. The 
ethyl acetate extract shows strong vasorelaxation (Rmax 81.6%), while the nonpolar hexane and polar Int. J. Mol. Sci. 2008, 9                                     
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methanol extracts exert comparable activity, with Rmax 65.67 and 65.09%, respectively. Significantly, 
the ethyl acetate extract exhibits immediate vasorelaxation with ED50 7.61×10
-8 mg/mL (Figure 4) 
when compared to the chloroform extract showing ED50 4.28×10
-7  mg/mL  
(Figure 3). This perhaps due to the fact that the ethyl acetate extract has higher affinity for the receptor 
than the chloroform extract and thus the ethyl acetate extract is the most potent vasorelaxant. 
Furthermore, the vasorelaxant activities of the tested extracts were all abolished by the removal of 
functional endothelial cells (Table 3 and Figure 6). This again confirms that the vasorelaxation of the 
extracts is modulated via NO production by endothelial cells, a fact which is known for Ach 
involvement in mediating vasorelaxation by NO, PGI2 and endothelium-derived hyperpolarizing factor 
[20-22]. Therefore, a set of experiments was studied in the presence of INDO (1 mM) compared with 
L-NAME (1mM). The results (Table 4) show that the vasorelaxation of the tested extracts (Figure 8) 
and ACh (Figure 7) is significantly reduced in a dose-dependent manner when compared to that of in 
the presence of L-NAME. Particularly, the INDO exhibits stronger reduction of such vasorelaxation 
than the L-NAME, but none was not observed for the SNP (Figure 9). Additionally, in the presence of 
INDO (1 mM) plus L-NAME (1 mM), synergistic effects are observed, leading to complete loss of the 
activity of the tested extracts and ACh. However, such an effect is not markedly noticeable for the 
SNP. These data confirm that the vasorelaxant activity of Spilanthes acmella Murr. is exerted by 
functional endothelial cells producing partial synthesis of NO and PGI2 which are inhibited by L-
NAME and INDO, respectively. NO is an important signaling molecule implicated in cardiovascular 
functions such as vascular tone. PGI2, endothelium-derived relaxing factor (EDRF), is a powerful 
vasorelaxant and antioxidant. It exerts antifibrotic properties preventing the development of fibrosis 
and cirrhosis in liver diseases including antiplatelet aggregation. PGI2 is clinically used for treatment 
of pulmonary hypertension and portopulmonary hypertension [23]. 
Many studies have reported the role of NO related to superoxide radical (O2
·-) [24]. Thus, the 
antioxidative activity of the extracts was evaluated. It was found that the plant extracts exhibited 
antioxidant activity at 200 µg/mL. In a DPPH assay, the polar ethyl acetate and methanol extracts 
exerted the highest radical scavenging activity, while the chloroform extract shows the highest SOD 
activity. The nonpolar hexane extract produces some activity in both the DPPH and SOD assays. 
It is noted that the ethyl acetate extract is the most potent, with immediate vasorelaxation and with 
the highest radical scavenging activity. This is presumably due to the presence of bioactive polar 
phenolic and triterpenoid ester compounds in the extract. Moreover, the chloroform extract possesses 
the highest Rmax accompanied by the highest SOD activity. This may result from the presence of 
triterpenoids and fatty alcohols or esters in this extract. Moderate vasorelaxations are observed for the 
nonpolar hexane and polar methanol extracts. This suggests that both hydrophobic and hydrophilic 
constituents show comparable vasorelaxant activity (Table 2). At this point, the ethyl acetate extract is 
the most promising vasorelaxant, with a significant ED50 of 76.1 ng/mL and it is also the most active 
antioxidant (DPPH assay). It has been reported that flavonoid, phenolic, polyphenol and triterpenoid 
compounds exhibit both vasorelaxant and antioxidant activities, in some cases behaving as either 
vasorelaxants or antioxidants [24-26]. Therefore, our results imply a good correlation between 
vasorelaxant and antioxidant activities deriving from a diverse group of compounds. 
It is well recognized that endothelium NO is diminished by reacting with O2
·- to form peroxynitrite 
as a potent oxidant, which is inhibited by antioxidant, thus in turn improving NO induced Int. J. Mol. Sci. 2008, 9                                     
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vasorelaxation [24, 27-29]. This was evidenced by phenolic antioxidants such as prinsepiol isolated 
from roots of Valeriana prionophylla [24]. A number of flavonoids exerted vasorelaxation through 
endothelium produced NO, e.g. chrysin (5, 7-dihydroxyflavone) presented in honey, propolis, fruits, 
vegetables and beverages [30-32], isoliquiritigenin isolated from various plants such as Dahlia 
variabilis [33] and recently from Hydnophytum formicarum Jack. [34]. Triterpenoids are commonly 
found in plant species, for instances, oleanolic acid and erythrodiol elicit vasorelaxation via 
endothelium induced NO [26]. In addition, root extracts of Caesalpinia benthamiana, which are rich in 
phenolic compounds, e.g. gallic acid, resveratrol and tannin, had significant vasorelaxant and powerful 
scavenging activity versus O2
·- [25]. Some plant extracts of Casimiroa edulis and Mammea africana 
(Guttiferae) caused vasorelaxation through endothelium dependent producing NO [35, 36]. The 
vasorelaxation was also mediated by both endothelium dependent and endothelium independent 
pathways [37]. Moreover, extracts of ethnomedical plant used as antihypertensive and anti-stroke 
exhibited their vasorelaxants via endothelium dependent producing NO or via direct stimulation of NO 
release. Examples are Diospyros kaki Thunb., Polygonum aviculare L., Magnolia liliflora Desr., 
Sorbus commixta Hedl, Selaginella tamariscina Spr. and Guazuma ulmifolia [38, 39]. 
In this study, Spilanthes acmella Murr. extracts produce vasorelaxation via partial release of NO 
and PGI2 from endothelium as well as showing antioxidant activities. Some countries in Asia including 
Thailand use this plant as fresh vegetable and cooking ingredient [40]. This demonstrates beneficial 
effects and applications of the Spilanthes acmella Murr. to medical uses and as a health food. 
 
4. Experimental Section 
 
4.1. Materials 
 
4.1.1. Chemicals 
 
L-Phenylephrine hydrochloride, sodium nitroprusside, N
G-nitro-L-arginine methyl ester, 
acetylcholine, ketamine hydrochloride and indomethacin were obtained from Sigma Chemical Co. (St. 
Louis, MO, USA). Polyethyleneglycol was purchased from Fluka. Plant extracts were dissolved in 
PEG, while methanol extract was dissolved in 0.9% normal saline. Then the solutions were further 
diluted by normal saline. 
 
4.1.2. Plant materials 
 
Aerial parts of Spilanthes acmella Murr. were collected from Nakornsrithammarat Province, 
Thailand. It has been identified (BKF 112361) by The Forest Herbarium, Royal Forestry Department. 
A voucher specimen has been deposited at Department of Chemistry, Faculty of Science, 
Srinakharinwirot University, Thailand. Int. J. Mol. Sci. 2008, 9                                     
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4.2. Methods 
 
4.2.1. Extraction 
 
The air dried Spilanthes acmella Murr. (1,050 g) was ground and extracted with hexane   
(3×5 days), followed by filtration. The filtrates were combined and evaporated in vacuo to give a crude 
hexane extract (11 g). Similarly, the extraction was performed using chloroform, ethyl acetate and 
methanol to obtain the corresponding chloroform (10 g), ethyl acetate (18 g) and methanol (31 g) 
extracts, respectively. 
 
4.2.2. Components and HPLC profiles of the extracts 
 
TLC chromatograms of the extracts were run on pre-coated silica gel 60F254 (Merck). Phenolic 
groups were detected by UV fluorescence. Their IR (neat, Perkin Elmer Spectrum One   
FT–IR spectrometer) and 
1H-NMR (CDCl3 or DMSO-d6, Bruker Avance 300 MHz) spectra were 
recorded. HPLC profiles were performed with flow rate 1 mL/min using a Hichrom Exsil 100-5ODS 
column (25 cm length with 4.6 mm diameter) and a Waters 2996 Photodiode Array Detector. The 
tested extracts were prepared by dissolving 1 mg in 1 mL methanol. Aliquots of 20 µL were injected 
using gradient elution with decreasing polarity from H2O: CH3OH (9:1) to CH3OH and running for 
100 min. Peaks of components were detected at 228.0 nm (hexane, chloroform and ethyl acetate 
extracts) and at 280.0 nm (methanol extract).  
 
4.2.3. Biological activity 
 
The study was performed using the hexane, chloroform, ethyl acetate and methanol extracts of 
Spilanthes acmella Murr., obtained as described above. 
 
4.2.3.1. Vasorelaxant assay 
 
4.2.3.1.1. Isometric tension measurements 
 
The protocols for handling animals were approved by the Animal Care Committee at the 
Srinakharinwirot University and done at the National Laboratory Animal Centre, Mahidol University. 
Male Sprague-Dawley rats (170-250 g) were anesthetized with intraperitoneal ketamine hydrochloride 
(0.05 mL/kg). The thoracic aorta was quickly removed to cold Kreb-Henseleit buffer containing (mM): 
118 NaCl; 4.7 KCl; 1.2 KH2PO4; 1.2 MgSO4·7H2O; 11.0(+)-glucose; 25.0 NaHCO3; and 2.5 
CaCl2·2H2O, pH 7.4, aerated with 95% O2, 5% CO2. After removed debris tissue, the vessel was cut 
into rings, each 2-3 mm-long and hanged in the organ bath containing Kreb-Henseleit solution at  
37 °C, aerated with 95% O2, 5% CO2 and also connected to a force-displacement transducer (Model 
MLTO50 Force transducer Range: 50, P.R. China) and equilibrated for 50-60 min under a 1 g resting 
tension. During an incubation period, the Kreb-Henseleit solution was changed every 20 min. After the 
incubation period, the maximal contraction of the rings was determined with high dose of PE (10
-5 M) Int. J. Mol. Sci. 2008, 9                                     
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and then washed 5 times until resting tension was recovered. Isometric tension [41] was recorded by 
Macintosh MacLab 4E AD Instrument connected to computer hard drive. The endothelial intact was 
examined using high dose of ACh (10
-5 M) at a level of submaximal tension. If the relaxation response 
to ACh was less than 80%, the ring would be discarded. Then, the ring was washed 5 times to remove 
the residue of ACh. The vessel was again equilibrated for 50-60 min and the responses of vessel were 
performed by the following protocols. Submaximal contraction was induced using PE (10
-7 M), then 
cumulative dose-response curves to the agonists (10
-9-10
-4 M or mg/mL). Finally, the dose-response 
curve of SNP was performed in order to test the functional vessel. With inhibitors (L-NAME or 
INDO) or vehicle, the vessels were pretreated with such compounds prior to submaximal contraction 
with PE then examine the endothelial response to the tested compounds. After each cumulative dose-
response curve, the thoracic aorta preparation was washed and equilibrated 50-60 min before working 
on the next dose-response curve of tested compounds. 
 
4.2.3.1.2. Statistical analyses 
 
The unpaired two-tailed Student’s t test and one-way ANOVA were used in the statistical analysis 
when appropriate. Post-hoc comparisons of individual groups were performed using the Tukey-
Kramer test. The ED50 values for the vasorelaxants were calculated using nonlinear regression 
analyses (GraphPad Prism 4, GraphPad Software Inc., Sandiego, CA, USA). A p-value less than 0.05 
was considered significant. The data were expressed as mean ± s.e.m. for the number of animals. 
 
4.2.3.2. Antioxidative assay 
 
Two assay methods were used: 2,2-diphenyl-1-picrylhydrazyl (DPPH) and superoxide dismutase 
(SOD). The antioxidative activity of the crude extracts was elucidated by the DPPH radical scavenging 
assay [42]. When DPPH (a stable purple color) reacts with an antioxidant, it is reduced to yield a light-
yellow colored diphenylpicrylhydrazine. Color changes can be spectrophotometrically measured. In 
this study, experiment was initiated by preparing 0.2 mM solution of DPPH in methanol. One mL of 
this solution was added sample solution (1 mg/mL dissolved in methanol, 0.5 mL). After 30 min, 
absorbance was measured at 517 nm and the percentage of radical scavenging activity was calculated 
from the following equation: 
% Radical scavenging = (1-Abs.sample/Abs.cont)×100 
where Abs.cont is the absorbance of the control reaction and Abs.sample is the absorbance in the 
presence of sample. 
The SOD activity was assayed by measuring inhibition of the photoreduction of nitro blue 
tetrazolium (NBT) [43]. The indirect assay is comprised of several reactions: the photochemically 
excited riboflavin was first reduced by methionine into a semiquinone, which donated an electron to 
oxygen to form the superoxide source. The superoxide readily converted NBT into a purple formazan 
product. In this regard, the SOD activity was inversely related to the amount of formazan formation. 
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5. Conclusions 
 
Our findings report for the first time that Spilanthes acmella Murr. extracts possess vasorelaxant 
and antioxidant activities. The plant extracts elicit vasorelaxations via partially endothelium induced 
NO and PGI2 in a dose-dependent manner. However, other underlying mechanisms may participate. 
Significantly, the ethyl acetate extract exhibits immediate vasorelaxation in nanogram levels and is the 
most potent antioxidant in the DPPH assay. The chloroform extract displays the highest vasorelaxation 
with the highest antioxidant (SOD assay). Furthermore, the nonpolar hexane and polar methanol 
extracts show moderate vasorelaxant activity. This demonstrates an important role for Spilanthes 
acmella Murr. as a new natural source of vasodilators and antioxidants. Furthermore, the results 
provide a guideline to further isolate bioactive ingredient, essentially, from chloroform and ethyl 
acetate extracts. However, the methanol and hexane extracts are also interesting to explore. Hopefully, 
new constituents will be isolated and investigated for bioactivities. Particularly, mechanism of 
vasorelaxation in more details involved EDHF via different potassium channels will be investigated. 
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